TUG1 and laryngeal carcinoma: lncRNA TUG1 participated in the development of laryngeal carcinoma via inhibiting the activation of RhoA/rho associated coiled‐coil containing protein kinase (ROCK)/matrix metalloproteinase (MMPs) signalling pathway by miR-145-5p (Shenfa et al. 2019).